Therapeutic evaluation of sorafenib for hepatocellular carcinoma using contrast-enhanced ultrasonography: Preliminary result

The present study aimed to determine the usefulness of contrast-enhanced ultrasonography (CEUS) with Sonazoid in evaluating the therapeutic response to sorafenib for hepatocellular carcinoma (HCC). In total, 26 patients with advanced HCC who received sorafenib and were followed up by CEUS were enrol...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncol Lett
Auteurs principaux: SHIOZAWA, KAZUE, WATANABE, MANABU, IKEHARA, TAKASHI, KOGAME, MICHIO, KIKUCHI, YOSHINORI, IGARASHI, YOSHINORI, SUMINO, YASUKIYO
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2016
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4907316/
https://ncbi.nlm.nih.gov/pubmed/27347183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4669
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires